MUMBAI – As Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. embark on a new journey as a single company, the merger’s impact on the Indian pharmaceutical market is set to be wide-ranging, with a deeply expanded reach and influence on prescriptions.
A few experts suggest top tier companies may already be looking at taking on the combined marketing might of Sun-Ranbaxy and considering serious M&A proposals in areas that could bridge...